Back to dashboard
MedicaidCoverageLow impact

The Novavax COVID-19 Vaccine, Adjuvanted (2023-2024 Formula) is Excluded from Coverage

Nevada Medicaid·NV · Family Medicine, General Practice, Internal Medicine +2 more·Provider Announcement
Effective date
Sep 13, 2024
We identified it
Jun 21, 2026
Days to comply

Summary

Nevada Medicaid has excluded the Novavax COVID-19 Vaccine, Adjuvanted (2023-2024 Formula) from pharmacy coverage following FDA's announcement that it is no longer authorized for use. This affects billing for this specific vaccine formulation.

Action Required

Action needed
Immediately: Stop billing Nevada Medicaid for Novavax COVID-19 Vaccine, Adjuvanted (2023-2024 Formula). Billing team must update system to exclude this specific vaccine formulation from Nevada Medicaid claims. Use only FDA-authorized COVID-19 vaccines for Nevada Medicaid patients.